Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025
May 12, 2025
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Multiple New Multi-Commodity Targets
next post
Excellent Gold Intersections Verified at Kiimala Project

related articles

Element79 Gold Corp. Provides Chachas Community update

March 29, 2025

CLEO Further Expands Ovarian Cancer Trial with Siles...

December 10, 2024

Stardust Power Announces Year End 2024 Financial Results

March 28, 2025

Noble Minerals Acquires a Rare Earth Property in...

November 17, 2025

Lahontan Drills High Grade Oxide Gold from the...

February 24, 2026

Adrian Day: Gold Dips Bought Quickly, Price Run...

March 7, 2026

Ross Beaty: Gold’s Positive Drivers Still at Play,...

February 2, 2025

Anteros Expands Surface Base and Precious Metal Mineralization...

November 10, 2025

Unlocking a New High-Grade Antimony-Tungsten Structure Adds Potential...

February 25, 2025

Editor’s Picks: Trump to Lift Minnesota Mining Ban,...

June 14, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 4

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024
    • 5

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024

    Categories

    • Investing (3,716)
    • Latest News (2,300)
    • Politics (4,595)
    • Stocks (1,370)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved